Leaving More Than Your Fingerprint on the Intravenous Line: A Prospective Study on Propofol Anesthesia and Implications of Stopcock Contamination

被引:30
作者
Cole, Devon C. [1 ]
Baslanti, Tezcan Ozrazgat [1 ]
Gravenstein, Nikolaus L. [2 ]
Gravenstein, Nikolaus [1 ]
机构
[1] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
基金
美国国家卫生研究院;
关键词
IN-USE CONTAMINATION; POSTOPERATIVE INFECTIONS; STAPHYLOCOCCUS-AUREUS; MICROBIAL-GROWTH; TRANSMISSION; INFUSIONS; RISK;
D O I
10.1213/ANE.0b013e318292ed45
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: Acute care handling of IV stopcocks during anesthesia and surgery may result in contaminated IV tubing sets. In the context of widespread propofol use, a nutrient-rich hypnotic drug, we hypothesized that propofol anesthesia increases bacterial contamination of IV stopcocks and may compromise safety of IV tubing sets when continued to be used after propofol anesthesia. METHODS: We conducted an in vitro trial by collecting IV tubing sets at the time of,patient discharge from same-day ambulatory procedures performed with and without propofol anesthesia. These extension sets were then held at room temperature for 6, 24, or 48 hours. We cultured 50 samples at each interval for both cohorts. Quantitative cultures were done by aspirating the IV stopcock dead space and plating the aspirate on blood agar for colony count and speciation. RESULTS: Positive bacterial counts were recovered from 17.3% of propofol anesthesia stopcocks (26/150) and 18.6% of nonpropofol stopcocks (28/150). At 6 hours, the average bacterial counts from stopcocks with visible residual propofol was 44 colony forming units (CFU)/mL, compared with 41 CFU/mL with no visible residual propofol and 37 CFU/mL in nonpropofol anesthesia stopcocks. There was a 100-fold increase in bacterial number in contaminated stopcock dead spaces at 48 hours after propofol anesthesia. This difference remained significant when comparing positive counts from stopcocks with no visible residual propofol and nonpropofol anesthesia (P = 0.034). CONCLUSIONS: There is a covert incidence and degree of IV stopcock bacterial contamination during anesthesia which is aggravated by propofol anesthetic. Propofol anesthesia may increase risk for postoperative infection because of bacterial growth in IV stopcock dead spaces.
引用
收藏
页码:861 / 867
页数:7
相关论文
共 23 条
[1]   In-use contamination of propofol. A clinical study [J].
Bach, A ;
Motsch, J ;
Schmidt, H ;
Bottiger, BW ;
Bohrer, H ;
Martin, E ;
Sonntag, HG .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1997, 14 (02) :178-183
[2]   POSTOPERATIVE INFECTIONS TRACED TO CONTAMINATION OF AN INTRAVENOUS ANESTHETIC, PROPOFOL [J].
BENNETT, SN ;
MCNEIL, MM ;
BLAND, LA ;
ARDUINO, MJ ;
VILLARINO, ME ;
PERROTTA, DM ;
BURWEN, DR ;
WELBEL, SF ;
PEGUES, DA ;
STROUD, L ;
ZEITZ, PS ;
JARVIS, WR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (03) :147-154
[3]  
Chatzinikolaou I, 2003, 43 INT C ANT AG CHEM
[4]  
CRICHTON EP, 1973, AM J CLIN PATHOL, V59, P199
[5]   DO INFUSIONS OF MIDAZOLAM AND PROPOFOL POSE AN INFECTION RISK TO CRITICALLY ILL PATIENTS [J].
FARRINGTON, M ;
MCGINNES, J ;
MATTHEWS, I ;
PARK, GR .
BRITISH JOURNAL OF ANAESTHESIA, 1994, 72 (04) :415-417
[6]   Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space [J].
Fukada, T. ;
Ozaki, M. .
ANAESTHESIA, 2007, 62 (06) :575-580
[7]  
Greenberg AE, 1998, STANDARD METHODS EXA, P921
[8]   Association of preservative-free propofol use and outcome in critically ill patients [J].
Haddad, Samir ;
Tamim, Hani ;
Memish, Ziad A. ;
Arabi, Yaseen .
AMERICAN JOURNAL OF INFECTION CONTROL, 2011, 39 (02) :141-147
[9]   Diagnosis of catheter-related bloodstream infection [J].
Hanna R. ;
Raad I.I. .
Current Infectious Disease Reports, 2005, 7 (6) :413-419
[10]   Growth of Staphylococcus aureus in Diprivan and Intralipid -: Implications on the pathogenesis of infections [J].
Langevin, PB ;
Gravenstein, N ;
Doyle, TJ ;
Roberts, SA ;
Skinner, S ;
Langevin, SO ;
Gulig, PA .
ANESTHESIOLOGY, 1999, 91 (05) :1394-1400